Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS) : study protocol for a randomized controlled trial

Sullivan, F. M.Farmer, EoghanMair, Frances STreweek, ShaunKendrick, DeniseJackson, CathyRobertson, ChrisBriggs, AndrewMcCowan, ColinBedford, LauraYoung, BenVedhara, KavitaGallant, StephanieLittleford, RobertaRobertson, JohnSewell, HerbDorward, AlistairSarvesvaran, JosephSchembri, Stuart2017-03-132017-03-132017-03-11Sullivan, F M, Farmer, E, Mair, F S, Treweek, S, Kendrick, D, Jackson, C, Robertson, C, Briggs, A, McCowan, C, Bedford, L, Young, B, Vedhara, K, Gallant, S, Littleford, R, Robertson, J, Sewell, H, Dorward, A, Sarvesvaran, J & Schembri, S 2017, 'Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS) : study protocol for a randomized controlled trial', BMC Cancer, vol. 17, 187. https://doi.org/10.1186/s12885-017-3175-y1471-2407ORCID: /0000-0002-7239-7241/work/186968588http://hdl.handle.net/2164/8324Funding for the study was provided by the Chief Scientist Office, Scottish Government and Oncimmune Ltd.459555engSDG 3 - Good Health and Well-beinglung cancerearly diagnosisscreeninghealth economicsRCTprimary carebiomarkerautoantibodiesR MedicineChief Scientist Office (CSO)RDetection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS) : study protocol for a randomized controlled trialJournal article10.1186/s12885-017-3175-y17